Cancer Therapy-Induced Cardiotoxicity: A Narrative Review.
This narrative review outlines current knowledge on cancer therapy–induced cardiotoxicity (CTIC), emphasizing that car...
Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An Evaluation.
- Post category:Supportive Oncology
- Reading time:1 min read
This territory‑wide Taiwanese cohort study evaluated adults with cancer‑associated thrombosis initially treated with...
A unified framework for pre-screening and screening tools in oncology clinical trials.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication is a narrative review of current and emerging approaches to identifying and enrolling oncology patients...
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication describes the design and aims of the CHARM2 trial, a Canadian, prospective randomized controlled study...
Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy.
- Post category:Supportive Oncology
- Reading time:2 mins read
This study reports the development of an oncolytic adenovirus engineered to express a trispecific T‑cell engager (TriT...
Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real-World Analysis in Japanese Patients.
- Post category:Supportive Oncology
- Reading time:2 mins read
This study evaluated tumor mutational burden (TMB) as a real-world predictor of pembrolizumab efficacy in a large Japane...